Author:
Mross K.,Hamm K.,Hossfeld D. K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference34 articles.
1. Busch FW, Schmittele U, Ehninger G (1990) Toxicity of novel anthracycline derivates towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil. Blut 60: 219?222
2. Cairo MS, Siegel S, Anas N, Sender L (1989) Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP-16 in drug-resistant pediatric tumors. Cancer Res 49: 1063?1066
3. Camaggi CM, Strocchi E, Comparsi R, Testoni F, Angelelli B, Pannuti F (1986) Biliary excretion and pharmacokinetics of 4?-epidoxorubicin in advanced cancer patients. Cancer Chemother Pharmacol 18: 47?50
4. Cummings J, Milstead R, Cunningham D, Kaye S (1986) Marked inter-patient variation in Adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum. Eur J Cancer Clin Oncol 22: 991?1001
5. Cummings J, Willmott N, Hoey BM, Smyth JF (1992) The consequences and significance of doxorubicin quinone reduction in vivo in tumor tissues. Ann Oncol 3 [Suppl 1]: 185
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献